Home/Pipeline/Sporadic AD iPSC Line Collection

Sporadic AD iPSC Line Collection

Alzheimer's Disease

Research/Preclinical ToolsActive

Key Facts

Indication

Alzheimer's Disease

Phase

Research/Preclinical Tools

Status

Active

Company

Axol Bioscience

About Axol Bioscience

Axol Bioscience is a leading provider of human iPSC-derived cells and contract services, operating as a critical enabler for drug discovery in human disease modeling. With over a decade of expertise, the company manufactures functional cells like cardiomyocytes and neurons and offers services including custom cell production, disease model creation, reprogramming, and gene editing. It holds ISO 9001:2015 certification for manufacturing and serves a global clientele, positioning itself at the intersection of the growing iPSC tools and services market. The company is privately held and appears to be in a revenue-generating stage, supported by its portfolio of products and collaborative projects.

View full company profile

Therapeutic Areas

Neuroscience Ophthalmology Cardiovascular Dermatology

Other Alzheimer's Disease Drugs

Drug	Company	Phase	Status
NUZ-001	Neurizon Therapeutics	Preclinical	Active
ALZN002	Alzamend Neuro	Preclinical	Research
P021	Phanes Biotech	Preclinical	Active
PB43D	Phanes Biotech	Preclinical	Active
UB-311	Vaxxinity	Phase 2	Active
Lecanemab	BioArctic	Launched	Active (Commercial)
BAN2401	BioArctic	Preclinical	Active
Undisclosed Programs	johnson-and-johnson-innovative-medicine	Pipeline	Active
MK-6240 (florquinitau)	Lantheus Medical Imaging	Regulatory Filing	Filed
NAV-4694 (flutafuranol)	Lantheus Medical Imaging	Phase 3	Active
LNTH-2620/PI-2620	Lantheus Medical Imaging	Phase 3	Recruiting
itMSCs	Stemedica Cell Technologies	Clinical Development	Active